Abstract:Purpose: The molecular mechanisms of age-related bone loss are unclear and without valid drugs yet. The aims of this study were to explore the molecular changes that occur in bone tissue during age-related bone loss, to further clarify the changes in function, and to predict potential therapeutic drugs. Methods: We collected bone tissues from children, middle-aged individuals, and elderly people for protein sequencing and compared the three groups of proteins pairwise, and the differentially expressed proteins (DEPs) in each group were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). K-means cluster analysis was then used to screen out proteins that continuously increased/decreased with age. Canonical signaling pathways that were activated or inhibited in bone tissue along with increasing age were identified by Ingenuity Pathway Analysis (IPA). Prediction of potential drugs was performed using the Connectivity Map (CMap). Finally, DEPs from sequencing were verified by Western blot, and the drug treatment effect was verified by quantitative real-time PCR. Results: The GO and KEGG analyses show that the DEPs were associated with inflammation and bone formation with aging, and the IPA analysis shows that pathways such as IL-8 signaling and acute-phase response signaling were activated, while glycolysis I and EIF2 signaling were inhibited. A total of nine potential drugs were predicted, with rapamycin ranking the highest. In cellular experiments, rapamycin reduced the senescence phenotype produced by the H2O2-stimulated osteocyte-like cell MLO-Y4. Conclusion: With age, inflammatory pathways are activated in bone tissue, and signals that promote bone formation are inhibited. This study contributes to the understanding of the molecular changes that occur in bone tissue during age-related bone loss and provides evidence that rapamycin is a drug of potential clinical value for this disease. The therapeutic effects of the drug are to be further studied in animals.

Decreased Activity of Osteocyte Autophagy with Aging May Contribute to the Bone Loss in Senile Population

Autophagy: A Promising Target for Age-related Osteoporosis

Increased activity of osteocyte autophagy in ovariectomized rats and its correlation with oxidative stress status and bone loss.

Autophagy Regulates Age-Related Jawbone Loss via LepR+ Stromal Cells

Metabolic shifts in ratio of ucOcn to cOcn toward bone resorption contribute to age-dependent bone loss in male mice

Regulatory cellular and molecular networks in the bone microenvironment during aging

Aging and Autophagy: Roles in Musculoskeletal System Injury

Senility changes of osteoblasts and osteoclasts and their role in aging bone loss

Autophagy regulates age-related delayed jawbone regeneration and decreased osteoblast osteogenesis by degrading FABP3

Inflammation produced by senescent osteocytes mediates age-related bone loss

Activation of 4-1BB signaling in bone marrow stromal cells triggers bone loss via the p-38 MAPK-DKK1 axis in aged mice

Aging impairs the osteocytic regulation of collagen integrity and bone quality

Loss of chaperone-mediated autophagy does not alter age-related bone loss in male mice

Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging

The age-related characteristics in bone microarchitecture, osteoclast distribution pattern, functional and transcriptomic alterations of BMSCs in mice

Ageing characteristics of bone indicated by transcriptomic and exosomal proteomic analysis of cortical bone cells

Autophagy in Bone Remodeling: A Regulator of Oxidative Stress

Degeneration of the osteocyte network in the C57BL/6 mouse model of aging

Loss of Rictor with Aging in Osteoblasts Promotes Age-Related Bone Loss

Osteocyte apoptosis: the roles and key molecular mechanisms in resorption-related bone diseases

Targeting autophagy receptors OPTN and SQSTM1 as a novel therapeutic strategy for osteoporosis complicated with Alzheimer's disease